DiaMedica Therapeutics (DMAC) Shareholder's Equity (2017 - 2026)
DiaMedica Therapeutics (DMAC) Shareholder's Equity (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
502.95 Mn |
| 10 |
DiaMedica Therapeutics |
285.11 Mn |
233.77 Mn |
- |
47.24 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
47.24 Mn |
| Dec 31, 2025 |
56.11 Mn |
| Sep 30, 2025 |
51.62 Mn |
| Jun 30, 2025 |
27.17 Mn |
| Mar 31, 2025 |
33.95 Mn |
| Dec 31, 2024 |
40.72 Mn |
| Sep 30, 2024 |
47.96 Mn |
| Jun 30, 2024 |
53.42 Mn |
| Mar 31, 2024 |
46.35 Mn |
| Dec 31, 2023 |
51.06 Mn |
| Sep 30, 2023 |
55.63 Mn |
| Jun 30, 2023 |
59.74 Mn |
| Mar 31, 2023 |
27.02 Mn |
| Dec 31, 2022 |
31.83 Mn |
| Sep 30, 2022 |
35.08 Mn |
| Jun 30, 2022 |
37.72 Mn |
| Mar 31, 2022 |
40.77 Mn |
| Dec 31, 2021 |
44.02 Mn |
| Sep 30, 2021 |
47.04 Mn |
| Jun 30, 2021 |
20.32 Mn |
